This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Piramal Imaging Announces The Acceptance For Review Of [18F] Florbetaben By The FDA And EMA For The Visual Detection Of Beta-amyloid In Alzheimer's Disease

About florbetaben

[ 18F] florbetaben is an 18F-labeled tracer for use in positron emission tomography (PET) which specifically binds to beta-amyloid deposits in the brain, a key pathological hallmark in Alzheimer's disease. A Phase III trial presented for the first time at the annual meeting of the American Academy of Neurology in 2012 showed that PET imaging with [ 18F] florbetaben detects beta-amyloid in the brains of living subjects. The visual assessment procedure proposed for routine clinical practice demonstrated 100% sensitivity and 92% specificity.

About Alzheimer's disease

Alzheimer's disease is a progressive neurodegenerative disease which primarily affects people over the age of 60 and is the most common cause of dementia. In 2009 estimates suggested that more than 36 million people worldwide were suffering from Alzheimer's. This figure could exceed 115 million by 2050. At present there is no cure for the disease, although treatments which may help with certain symptoms, combined with the right services and support, can improve the quality of life for the millions of people living with Alzheimer's.

About Piramal Enterprises Ltd.

Piramal Enterprises is one of India's largest diversified companies with operations in pharmaceuticals, financial services and information management. Piramal Enterprises generated consolidated revenues of $500 million in the 2012 financial year. In pharmaceuticals field, Piramal Enterprises is one of the leading custom manufacturing players in the world and operates in the global critical-care segment with a portfolio of inhalation and injectable anesthetics. Its OTC business is ranked number 7 in India. PEL is also involved in drug discovery & research and has strong pipeline of development products. In the financial services field, PEL has a real-estate-focused PE fund called Indiareit, and an NBFC that focuses on lending to the real-estate and education sector. Recently, PEL also entered the global information-management industry by acquiring the US-based company Decision Resources Group. PEL acquired the global rights to a molecular-imaging research and development portfolio from Bayer AG. The portfolio includes the rights to [ 18F] florbetaben, a highly specialized molecule used in PET imaging to detect beta-amyloid in the brain, a widely recognized marker for Alzheimer's disease.

About Piramal Imaging SA

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs